HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Combining Liver and Pancreatic Resections Is Safe

By HospiMedica International staff writers
Posted on 15 Apr 2014
Print article
Combined liver and pancreatic resection (CLPR) is safe and can be performed with fairly low morbidity and mortality rates, according to a new study.

Researchers at the University of Strasbourg (France) conducted a review of two prospectively maintained databases for pancreatic and liver resections to identify patients who underwent CLPR between January 1994 and January 2012. The researchers then examined the clinical, pathological, and surgical outcomes and analyzed postoperative morbidity results. In all, 50 consecutive patients with a median age of 58 years underwent CLPR. Indications for surgery included neuroendocrine carcinoma (16 patients), biliary cancer (15), colonic cancer (5), duodenal cancer (1), and others (13).

The type of pancreatic resection included pancreaticoduodenectomy (30), distal pancreatectomy (17), spleen-preserving distal pancreatectomy (2) and total pancreatectomy (1). Twenty-three patients had associated major hepatectomies, 27 underwent minor liver resections, and 11 had associated vascular resections. The analysis showed no differences in postoperative morbidity in relation to extent of liver resection or type of pancreatic resection. The use of preoperative chemotherapy was the only independent risk factor associated with postoperative morbidity. The study was published on April 4, 2014, in the British Journal of Surgery.

“In Western countries, combined liver and pancreatic resections are performed rarely because of the perceived high morbidity and mortality rates,” said lead author Pietro Addeo, MD, of the University of Strasbourg Hôpital de Hautepierre-Hôpitaux, adding that the new study showed that “CLPR can be performed with fairly low morbidity and mortality rates. Patients receiving chemotherapy should be evaluated carefully before surgery is considered.”

Combined resection of both the liver and pancreas remains a controversial procedure. For many, the need for such an extended procedure implies a scope of disease spread that is usually not amenable to surgical control, and the extent of the procedure exposes the patients to substantial operative risks.

Related Links:

University of Strasbourg



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ultrasound System
Voluson Signature 18

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more